Fig. 2From: Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controlsPrincipal component analyses of the cohort using the 12 cluster-representative metabolites from the ESI-positive and ESI-negative modesBack to article page